Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)

Plain-language summary

This study investigates whether diabetes and prediabetes can be diagnosed in patients with Dunnigan-type partial familial lipodystrophy using a standardized carbohydrate breakfast and continuous tissue glucose monitoring instead of a standard glucose test. It enrolls these patients aged 18-75 who are not known to be diabetic. It is a study without an assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire de la Réunion

Intervention

Standardized breakfast

Start date

6/19/2023

Estimated completion

6/30/2025

Countries

Reunion

Related genes

Locations

• Saint-Denis, Reunion

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Subject with Dunnigan's partial familial lipodystrophy followed at Reunion University Hospital not known to be diabetic.

Aged 18 to 75 Having given their informed consent.

Exclusion Criteria:

* Diabetic patient Patient scheduled for scan within 7 days of freestyle placement protected persons: "pregnant woman, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, minor, and person subject to a measure of legal protection: guardianship or curatorship)"